Turin · Pre-Seed–Series A · 13 people tracked
Find your way into Claris Ventures
1,294 people in our graph share verified history with the Claris Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Claris Ventures backs early-stage biopharma companies that combine a clear vision with solid scientific evidence. The firm targets innovators addressing significant unmet clinical needs across areas including rare diseases, oncology and immunology, as well as other life-threatening disease areas. Beyond capital, Claris provides scientific competence and hands-on support to help jump-start clinical development programs, aiming to create value driven by clinical evidence. Its fund, Claris Biotech I, is backed by European institutional programs including InnovFin Equity under Horizon 2020, the European Fund for Strategic Investments, AlpGIP, and the Pan-European Guarantee Fund.
Source: firm website, verified Aug 3, 2026.
Team · 13 people
from the firm's website & public directories
Founder mafia
2 people who came through Claris Ventures went on to found or lead other companies.
What they invest in
from 10 of 12 portfolio companiesBiotech ×10Healthtech ×5Medical Devices ×4Deep Tech ×3AI & Machine Learning ×2Longevity ×2Digital Health ×1
HQs:Italy×3
Investments · 12 tracked
founders shown can be your intro pathBy year:2025 · 32023 · 12022 · 15 dated
Lever Bio develops immunotherapy drug candidates in immuno-oncology, partnering with top researchers and academic institutions to translate discoveries into cancer immunotherapies.
BiotechDeep TechHealthtechMedical Devices
Pietro Puglisi(Chief Executive Officer)in
Co-investorsExor VenturesItalian Angels for GrowthClub degli InvestitoriOra Global
ALKemist Bio develops immunotherapies targeting the ALK oncogene in cancer by engineering autologous T cells with synthetic receptors to recognize and eliminate ALK-positive tumor cells.
BiotechDigital HealthMedical Devices
Roberto Chiarle
Co-investorsClub degli InvestitoriItalian Angels for GrowthLIFTT
Heqet Therapeutics is a pre-clinical stage biotech developing non-coding RNA-based therapies for cardiovascular diseases, with a focus on acute myocardial infarction.
BiotechMedical Devices
Mauro Giacca(Founder (Professor of Cardiovascular Sciences))
IAMA Therapeutics develops small-molecule drugs for autism, epilepsies, and other central nervous system disorders, focusing on inhibiting cation-chloride cotransporters to correct atypical brain activity.
BiotechDeep Tech
Co-investorsCDP Venture CapitalIndaco Venture Partners
Kither Biotech is a clinical-stage biotech company developing inhaled cell signal transduction modulators targeting the PI3Kγ signaling axis for respiratory diseases such as COPD, non-cystic fibrosis bronchiectasis, cystic fibrosis, and idiopathic pulmonary fibrosis.
BiotechHealthtech
Co-investors3B Future Health FundCDP Venture CapitalElysia CapitalItalian Angels for Growth
Neophore develops a small-molecule therapeutic that transiently inhibits DNA Mismatch Repair (MMR) to convert MMR-proficient tumours into an MMR-deficient state, making them responsive to cancer immunotherapy.
AI & Machine LearningBiotechLongevity
Co-investors3B Future Health FundAstellas Venture Management LLCNeva Sgr.
PAGE Therapeutics is an oncology drug development company developing compounds that disrupt cell-cell adhesion to dissolve circulating tumor cell (CTC) clusters and block cancer metastasis.
BiotechHealthtech
Nicola Aceto(Co-founder & Chief Science Officer)inChristoph Rochlitz(Co-founder & Chief Medical Officer)inDaniele Scarinci(CEO & Executive Director)inKatharina Venturi(Chief Operating Officer)in
Co-investorsXGEN Venture
Resalis Therapeutics develops antisense oligonucleotide therapies targeting microRNA pathways for metabolic disorders.
BiotechHealthtechLongevityMedical DevicesTurin, IT
Riccardo Panella(Chief Scientific Officer & Co-Founder)inSakari Kauppinen(Chief Technology Officer & Co-Founder)in
Co-investorsItalian Angels for GrowthSunstone Capital
Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.
AI & Machine LearningBiotechDeep TechTrento, IT
Emiliano Biasini(Co-founder)inPietro Faccioli(Co-founder)inGiovanni Spagnolli(Co-founder, CTO)inMaria Letizia Barreca(Co-founder)inGraziano Lolli(Co-founder)
Co-investors3B Future Health FundCDP Venture CapitalSeroba Life SciencesV-Bio VenturesVertis SGRVI Partners+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Arbitro per le Controversie FinanziarieRepron Therapeutics
Portfolio news
latest coverage across their companiesLever Bio · trysignalbase.com · Dec 22, 2025
Haptena · startupbusiness.it · Dec 16, 2025
Frequently asked questions
- How many investments has Claris Ventures made?
- Claris Ventures has 12 tracked investments, including 3 dated in the last 24 months.
- What stage does Claris Ventures invest at?
- Claris Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Claris Ventures focus on?
- Claris Ventures focuses on Biotech, Healthtech, Medical Devices.
- Where is Claris Ventures located?
- Claris Ventures is headquartered in Turin, IT.
- Does Claris Ventures lead rounds?
- Claris Ventures typically participates in rounds rather than leading them.
- Who does Claris Ventures co-invest with?
- Claris Ventures most often shares deals with Italian Angels for Growth, 3B Future Health Fund, CDP Venture Capital, among 12 tracked co-investors.
Media · Podcasts & interviews
featuring the teamPietro Puglisi (Claris Ventures): Sostenere la crescita e dare visione con investimenti nel settore
Sanità33 · Pietro Puglisi
Images
Co-investors · 3
CDP Venture Capital SGR is an Italian venture capital fund manager that invests in strategic sectors for Italy's economic growth through direct and indirect funds. It is Italy's leading VC fund manager and among the largest in Europe.
3B Future Health Fund invests in early-stage private healthcare and biotech companies in the US, Europe and Israel that address high unmet patient needs, with a focus on oncology and rare diseases.
Seroba is a Dublin-based life sciences venture capital firm investing in early-stage biotech and medtech companies developing new therapeutics and medical devices.
Firms observed investing alongside Claris Ventures, from public investor directories. Shared companies are the overlap with Claris Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.